Almstedt, K.
22  results:
Search for persons X
?
1

Low-dose metronomic chemotherapy as an efficient treatment ..:

Krajnak, S. ; Schnatz, C. ; Almstedt, K....
Breast Cancer Research and Treatment.  182 (2020)  2 - p. 389-399 , 2020
 
?
3

EndoPredict® in early hormone receptor-positive, HER2-negat..:

Almstedt, K. ; Mendoza, S. ; Otto, M....
Breast Cancer Research and Treatment.  182 (2020)  1 - p. 137-146 , 2020
 
?
5

Subtype-specific prognostic impact of different immune sign..:

Heimes, A.-S. ; Madjar, K. ; Edlund, K....
Breast Cancer Research and Treatment.  165 (2017)  2 - p. 293-300 , 2017
 
?
6

Prognostic significance of interferon regulating factor 4 (..:

Heimes, Anne-Sophie ; Madjar, K. ; Edlund, K....
Journal of Cancer Research and Clinical Oncology.  143 (2017)  7 - p. 1123-1131 , 2017
 
?
 
?
8

Complementary and alternative medicine and musculoskeletal ..:

Hack, C.C ; Häberle, L ; Brucker, S.Y...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377331/.  , 2020
 
?
9

EndoPredict(®) in early hormone receptor-positive, HER2-neg..:

Almstedt, K ; Mendoza, S ; Otto, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275019/.  , 2020
 
?
10

Complementary and alternative medicine and musculoskeletal ..:

C.C. Hack ; L. Häberle ; S.Y. Brucker...
http://www.sciencedirect.com/science/article/pii/S0960977620300011.  , 2020
 
?
11

#1926 Persistence to first- and second- generation potassiu..:

Svensson, Maria K Eriksson ; Furuland, Hans ; Larsson, Anders...
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
 
?
 
?
 
1-15